Drug comparisons
Erenumab vs Fremanezumab
Compare Erenumab (Aimovig) vs Fremanezumab (Ajovy) CGRP mAbs for migraine prevention. Receptor vs ligand targeting, monthly vs quarterly dosing, efficacy and safety.
No comparison dimensions are available for this page.
Clinical context
Patients and clinicians selecting a CGRP monoclonal antibody for preventive treatment of episodic or chronic migraine.
Bottom line
Both agents provide similar migraine-prevention efficacy; choice is driven by dosing schedule and tolerability rather than overall superiority.
All medication comparisons